Yumanity Therapeutics (YMTX) Stock Chart & Stock Price History → Special FREE offer on stock hotsheets (From DTI) (Ad) Free YMTX Stock Alerts $0.46 -0.01 (-2.11%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Yumanity Therapeutics Stock Price Performance5 Day Performance-0.92%1 Month Performance-17.17%3 Month Performance-47.85%6 Month Performance-88.67%Year-To-Date Performance-87.20%1 Year Performance-84.51% Receive YMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. YMTX Stock Chart for Sunday, June, 2, 2024 YMTX Chart by TradingView Yumanity Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.48$0.46-2.17%$0.49$0.4635,701 shs$5.05 million05/30/2024$0.48$0.48-0.84%$0.49$0.4817,462 shs$5.16 million05/29/2024$0.47$0.48+2.13%$0.49$0.46108,913 shs$5.20 million05/28/2024$0.46$0.47+1.67%$0.49$0.4536,029 shs$5.09 million05/27/2024$0.46$0.46$0.49$0.4421,471 shs$5.01 million05/24/2024$0.47$0.46-1.43%$0.49$0.4417,171 shs$5.01 million Get the Latest News and Ratings for YMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.48$0.47-1.63%$0.48$0.4430,143 shs$5.08 million05/22/2024$0.48$0.48-1.09%$0.49$0.4548,521 shs$5.17 million05/21/2024$0.48$0.48$0.50$0.45113,852 shs$5.22 million05/20/2024$0.45$0.48+6.42%$0.50$0.45103,827 shs$5.22 million05/17/2024$0.49$0.49$0.50$0.4453,742 shs$5.29 million05/16/2024$0.52$0.49-6.35%$0.50$0.4451,830 shs$5.29 million05/15/2024$0.52$0.52+0.00%$0.54$0.5146,616 shs$5.65 million05/14/2024$0.56$0.52-6.83%$0.60$0.50161,064 shs$5.65 million05/13/2024$0.56$0.56$0.63$0.5659,105 shs$6.06 million05/10/2024$0.63$0.56-10.70%$0.63$0.5657,567 shs$6.06 million05/09/2024$0.58$0.63+8.43%$0.65$0.53292,443 shs$6.79 million05/08/2024$0.58$0.58$0.61$0.5736,586 shs$6.26 million05/07/2024$0.59$0.58-2.29%$0.61$0.5736,578 shs$6.26 million05/06/2024$0.59$0.59$0.61$0.5367,152 shs$6.40 million05/03/2024$0.56$0.59+5.15%$0.61$0.5367,152 shs$6.40 million05/02/2024$0.55$0.56+1.81%$0.58$0.5056,753 shs$6.09 million05/01/2024$0.56$0.55-2.37%$0.62$0.55157,067 shs$5.98 million04/30/2024$0.59$0.56-3.60%$0.63$0.5463,269 shs$6.13 million04/29/2024$0.61$0.59-4.02%$0.61$0.5928,568 shs$6.36 million04/26/2024$0.62$0.61-1.61%$0.62$0.57130,623 shs$6.62 million04/25/2024$0.62$0.62$0.67$0.60172,767 shs$6.73 million04/24/2024$0.63$0.62-2.35%$0.67$0.60172,143 shs$6.73 million04/23/2024$0.63$0.63$0.74$0.51832,435 shs$6.89 million04/22/2024$0.53$0.63+20.47%$0.74$0.51818,607 shs$6.89 million04/19/2024$0.49$0.53+8.41%$0.55$0.49478,877 shs$5.72 million04/18/2024$0.47$0.49+3.43%$0.55$0.41838,282 shs$5.28 million04/17/2024$0.48$0.47-2.02%$0.52$0.42729,932 shs$5.10 million04/16/2024$0.34$0.48+41.09%$0.55$0.335.35 million shs$5.21 million04/15/2024$0.36$0.34-6.34%$0.39$0.34164,078 shs$3.69 million04/12/2024$0.44$0.44$0.47$0.37568,387 shs$4.78 million04/11/2024$0.37$0.44+18.92%$0.47$0.37555,284 shs$4.78 million04/10/2024$0.43$0.37-13.95%$0.43$0.35430,637 shs$4.02 million04/09/2024$0.56$0.43-23.20%$0.49$0.411.21 million shs$4.67 million04/08/2024$0.56$0.56$0.59$0.5366,101 shs$6.08 million2024's Must-Watch Stocks! (Ad)Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now]04/05/2024$0.56$0.56+0.43%$0.59$0.5366,101 shs$6.08 million04/04/2024$0.57$0.56-2.12%$0.60$0.53100,824 shs$6.05 million04/03/2024$0.49$0.57+15.42%$0.57$0.4754,385 shs$6.18 million04/02/2024$0.51$0.49-2.57%$0.53$0.4639,861 shs$5.36 million04/01/2024$0.53$0.51-3.58%$0.53$0.4645,791 shs$5.50 million03/29/2024$0.52$0.53+0.77%$0.57$0.41139,857 shs$5.70 million03/28/2024$0.52$0.52$0.60$0.5199,011 shs$5.66 million03/27/2024$0.56$0.52-6.19%$0.60$0.5198,910 shs$5.66 million03/26/2024$0.56$0.56$0.66$0.49140,641 shs$6.03 million03/25/2024$0.65$0.56-14.49%$0.66$0.49139,851 shs$6.03 million03/22/2024$0.57$0.65+15.03%$0.65$0.5594,129 shs$7.06 million03/21/2024$0.54$0.57+5.25%$0.58$0.5450,315 shs$6.13 million03/20/2024$0.56$0.54-3.59%$0.57$0.5052,782 shs$5.83 million03/19/2024$0.56$0.56$0.63$0.5379,427 shs$6.05 million03/18/2024$0.55$0.56+2.17%$0.63$0.5379,427 shs$6.05 million03/15/2024$0.62$0.61-0.75%$0.62$0.5559,294 shs$6.63 million03/14/2024$0.62$0.62$0.64$0.57100,497 shs$6.68 million03/13/2024$0.69$0.62-10.83%$0.64$0.57100,497 shs$6.68 million03/12/2024$0.69$0.69$0.76$0.6687,864 shs$7.49 million03/11/2024$0.70$0.69-0.72%$0.76$0.6687,864 shs$7.49 million03/08/2024$0.78$0.77-1.56%$0.81$0.7493,702 shs$8.34 million03/07/2024$0.78$0.78$0.90$0.76199,339 shs$8.47 million03/06/2024$1.01$0.78-22.75%$0.90$0.76199,315 shs$8.47 million03/05/2024$1.01$1.01$1.33$0.952.11 million shs$10.97 million03/04/2024$0.89$1.01+13.36%$1.33$0.952.08 million shs$10.97 million03/01/2024$2.26$0.89-60.58%$0.97$0.77246,559 shs$9.67 million Related Companies: Sonnet BioTherapeutics Stock Price Chart Bright Minds Biosciences Stock Price Chart Cingulate Stock Price Chart Processa Pharmaceuticals Stock Price Chart NovaBay Pharmaceuticals Stock Price Chart China Pharma Stock Price Chart Genprex Stock Price Chart Lipella Pharmaceuticals Stock Price Chart Clever Leaves Stock Price Chart Artelo Biosciences Stock Price Chart Receive YMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceThis military-backed stock “owns” AI marketPorter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.